Indication
Macular Ischemia
1 clinical trial
2 products
Clinical trial
Comparison of the Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema Using OCTAStatus: Terminated, Estimated PCD: 2022-09-01
Product
RanibizumabProduct
Bevacizumab